Optimizing heart failure management: An Australian experience

International Journal of Cardiology

Volumn 112, Issue 2, 2006, Pages 256-

  Barlis, Peter ^a   MacIsaac, Richard ^a   Hare, David L ^a   Burrell, Louise M ^a,b  

^a AUSTIN HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SPIRONOLACTONE;

ARTICLE; AUSTRALIA; BETA ADRENERGIC RECEPTOR BLOCKING; HEART FAILURE; HUMAN; MEDICAL PRACTICE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PATIENT EDUCATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT OUTCOME;

AGED; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; PATIENT CARE TEAM; PRACTICE GUIDELINES; QUALITY OF HEALTH CARE; VICTORIA;

EID: 33748451622     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2005.07.057     Document Type: Article

References (3)

1. Australian Institute of Health and Welfare. Heart, stroke and vascular diseases, Australian facts (2004), AIHW and Heart Foundation of Australia, Canberra AIHW Cat. No. CVD-27; Cardiovascular Disease Series No.22
2. Ryan R., Harding D., and Burrell L.M. Practice patterns after implementation of a clinical pathway for heat failure. Abstracts of the 24th Annual Scientific Meeting of the High Blood Pressure Research Council of Australia. Clin Exp Pharmacol Physiol 30 7 (2003) A31-A68
3. Krum H. Guidelines for management of patients with chronic heart failure in Australia. Med J Aust 174 (2001) 459-466